Congress has cut federal funding for public media — a $3.4 million loss for LAist. We count on readers like you to protect our nonprofit newsroom. Become a monthly member and sustain local journalism.
The patent feud between Moderna and the U.S. could have implications for the world
Listen
• 3:54
AUDIE CORNISH, HOST:
More than 164 million doses of the Moderna vaccine have been shot into the arms of Americans. Now, the drugmaker is feuding with the federal government about who gets credit for the genetic technology behind the shot. In patent filings, Moderna has asserted its scientists were solely responsible. Scientists from the National Institutes of Health, who spent years working alongside Moderna's team, say they've been left out. Now, the dispute could have global implications for the manufacture and distribution of the lifesaving vaccine.
Science writer Brendan Borrell chronicled the saga of the vaccine's development in his book "The First Shots." He joins us now. Welcome to the program.
BRENDAN BORRELL: Thanks for having me.
Support for LAist comes from
CORNISH: So our understanding of the kind of origin story of this technology is that NIH worked alongside private companies - right? - alongside Moderna to develop the vaccine. So what did that look like, and what exactly is Moderna claiming here?
BORRELL: The collaboration began in 2017. This group of vaccine researchers at the NIH basically started working with Moderna on HIV and with emerging infectious diseases, which have often been kind of a market loser for the vaccine world. I mean, most of the time, these emerging diseases, they arise and they vanish before you have anyone to test them on or to even - to roll out a product to.
So the researchers at NIH, they really liked Moderna because, unlike other pharmaceutical companies, the CEO, Stephane Bancel, he wanted to go after infectious diseases. And he and Barney Graham, the researcher at the Vaccine Research Center, they inked out a plan to basically run a pilot project where they would go after emerging infectious disease and prove to the world just how fast they could roll out vaccines. They entered into this collaboration with the hope that Moderna would actually bring something to the market. They did not expect to kind of lose the rights to it.
CORNISH: Is that what Moderna would like? Help us understand their claims.
BORRELL: Moderna claims that they independently came up with the design for the coronavirus vaccine and that NIH simply helped them test it.
CORNISH: This fight could determine how widely Moderna's mRNA technology is licensed and deployed around the globe. Can you describe the stakes? What does that mean?
BORRELL: Basically, by asserting that the vaccine is fully Moderna's, the NIH has no ability to sort of march in and demand that, say, the vaccine be manufactured by another company abroad. I think there's bigger issues here, too, which is that, you know, this vaccine was developed thanks to the basic biomedical research infrastructure we have in the United States paid by taxpayers. And I think we want some of the money. Moderna expects to earn $15 billion at least this year from the coronavirus vaccine, and some of that money needs to go back to basic research.
Support for LAist comes from
CORNISH: We're at the start of this dispute. As somebody who has done a lot of reporting, what are you going to be looking for or listening for as all of this gets untangled?
BORRELL: I think right now the question is, will legal action be taken? There have been filings in the U.S. patent court. Moderna said one thing. The NIH said the other. We're still a long way off for this being resolved. I mean, what's interesting to me is that Pfizer has paid to license this technology from the NIH. Moderna is holding its ground. So they are the last holdout.
CORNISH: Why do you think that is?
BORRELL: The company has a history of - it's basically been a patent filing machine throughout its existence. You know, this is a company that spent 10 years without developing a product, and it's finally able to reap some of the gains. And, you know, I think they feel very protective of that.
CORNISH: Brendan Borrell is the author of "The First Shots" - the story of Operation Warp Speed. Thank you for your time.
BORRELL: Thanks for having me. Transcript provided by NPR, Copyright NPR.
As Editor-in-Chief of our newsroom, I’m extremely proud of the work our top-notch journalists are doing here at LAist. We’re doing more hard-hitting watchdog journalism than ever before — powerful reporting on the economy, elections, climate and the homelessness crisis that is making a difference in your lives. At the same time, it’s never been more difficult to maintain a paywall-free, independent news source that informs, inspires, and engages everyone.
Simply put, we cannot do this essential work without your help. Federal funding for public media has been clawed back by Congress and that means LAist has lost $3.4 million in federal funding over the next two years. So we’re asking for your help. LAist has been there for you and we’re asking you to be here for us.
We rely on donations from readers like you to stay independent, which keeps our nonprofit newsroom strong and accountable to you.
No matter where you stand on the political spectrum, press freedom is at the core of keeping our nation free and fair. And as the landscape of free press changes, LAist will remain a voice you know and trust, but the amount of reader support we receive will help determine how strong of a newsroom we are going forward to cover the important news from our community.
Please take action today to support your trusted source for local news with a donation that makes sense for your budget.
Thank you for your generous support and believing in independent news.
Chip in now to fund your local journalism
(
LAist
)
Trending on LAist
-
After rising for years, the number of residential installations in the city of Los Angeles began to drop in 2023. The city isn’t subject to recent changes in state incentives, but other factors may be contributing to the decline. -
The L.A. City Council approved the venue change Wednesday, which organizers say will save $12 million in infrastructure costs.
-
Taxes on the sale of some newer apartment buildings would be lowered under a plan by Sacramento lawmakers to partially rein in city Measure ULA.
-
The union representing the restaurant's workers announced Tuesday that The Pantry will welcome back patrons after suddenly shutting down six months ago.
-
If approved, the more than 62-acre project would include 50 housing lots and a marina less than a mile from Jackie and Shadow's famous nest overlooking the lake.
-
The U.S. Supreme Court lifted limits on immigration sweeps in Southern California, overturning a lower court ruling that prohibited agents from stopping people based on their appearance.
Best of LAist